Cargando…

Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media

BACKGROUND: Scarce information about clinical research, in particular clinical trials, is among the top reasons why potential participants do not take part in clinical studies. Without volunteers, on the other hand, clinical research and the development of novel approaches to preventing, diagnosing,...

Descripción completa

Detalles Bibliográficos
Autores principales: Reuter, Katja, Ukpolo, Francis, Ward, Edward, Wilson, Melissa L, Angyan, Praveen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945821/
https://www.ncbi.nlm.nih.gov/pubmed/27357424
http://dx.doi.org/10.2196/jmir.4726
_version_ 1782442927740420096
author Reuter, Katja
Ukpolo, Francis
Ward, Edward
Wilson, Melissa L
Angyan, Praveen
author_facet Reuter, Katja
Ukpolo, Francis
Ward, Edward
Wilson, Melissa L
Angyan, Praveen
author_sort Reuter, Katja
collection PubMed
description BACKGROUND: Scarce information about clinical research, in particular clinical trials, is among the top reasons why potential participants do not take part in clinical studies. Without volunteers, on the other hand, clinical research and the development of novel approaches to preventing, diagnosing, and treating disease are impossible. Promising digital options such as social media have the potential to work alongside traditional methods to boost the promotion of clinical research. However, investigators and research institutions are challenged to leverage these innovations while saving time and resources. OBJECTIVE: To develop and test the efficiency of a Web-based tool that automates the generation and distribution of user-friendly social media messages about clinical trials. METHODS: Trial Promoter is developed in Ruby on Rails, HTML, cascading style sheet (CSS), and JavaScript. In order to test the tool and the correctness of the generated messages, clinical trials (n=46) were randomized into social media messages and distributed via the microblogging social media platform Twitter and the social network Facebook. The percent correct was calculated to determine the probability with which Trial Promoter generates accurate messages. RESULTS: During a 10-week testing phase, Trial Promoter automatically generated and published 525 user-friendly social media messages on Twitter and Facebook. On average, Trial Promoter correctly used the message templates and substituted the message parameters (text, URLs, and disease hashtags) 97.7% of the time (1563/1600). CONCLUSIONS: Trial Promoter may serve as a promising tool to render clinical trial promotion more efficient while requiring limited resources. It supports the distribution of any research or other types of content. The Trial Promoter code and installation instructions are freely available online.
format Online
Article
Text
id pubmed-4945821
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-49458212016-08-03 Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media Reuter, Katja Ukpolo, Francis Ward, Edward Wilson, Melissa L Angyan, Praveen J Med Internet Res Original Paper BACKGROUND: Scarce information about clinical research, in particular clinical trials, is among the top reasons why potential participants do not take part in clinical studies. Without volunteers, on the other hand, clinical research and the development of novel approaches to preventing, diagnosing, and treating disease are impossible. Promising digital options such as social media have the potential to work alongside traditional methods to boost the promotion of clinical research. However, investigators and research institutions are challenged to leverage these innovations while saving time and resources. OBJECTIVE: To develop and test the efficiency of a Web-based tool that automates the generation and distribution of user-friendly social media messages about clinical trials. METHODS: Trial Promoter is developed in Ruby on Rails, HTML, cascading style sheet (CSS), and JavaScript. In order to test the tool and the correctness of the generated messages, clinical trials (n=46) were randomized into social media messages and distributed via the microblogging social media platform Twitter and the social network Facebook. The percent correct was calculated to determine the probability with which Trial Promoter generates accurate messages. RESULTS: During a 10-week testing phase, Trial Promoter automatically generated and published 525 user-friendly social media messages on Twitter and Facebook. On average, Trial Promoter correctly used the message templates and substituted the message parameters (text, URLs, and disease hashtags) 97.7% of the time (1563/1600). CONCLUSIONS: Trial Promoter may serve as a promising tool to render clinical trial promotion more efficient while requiring limited resources. It supports the distribution of any research or other types of content. The Trial Promoter code and installation instructions are freely available online. JMIR Publications 2016-06-29 /pmc/articles/PMC4945821/ /pubmed/27357424 http://dx.doi.org/10.2196/jmir.4726 Text en ©Katja Reuter, Francis Ukpolo, Edward Ward, Melissa L Wilson, Praveen Angyan. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 29.06.2016. https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/ (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Reuter, Katja
Ukpolo, Francis
Ward, Edward
Wilson, Melissa L
Angyan, Praveen
Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media
title Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media
title_full Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media
title_fullStr Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media
title_full_unstemmed Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media
title_short Trial Promoter: A Web-Based Tool for Boosting the Promotion of Clinical Research Through Social Media
title_sort trial promoter: a web-based tool for boosting the promotion of clinical research through social media
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945821/
https://www.ncbi.nlm.nih.gov/pubmed/27357424
http://dx.doi.org/10.2196/jmir.4726
work_keys_str_mv AT reuterkatja trialpromoterawebbasedtoolforboostingthepromotionofclinicalresearchthroughsocialmedia
AT ukpolofrancis trialpromoterawebbasedtoolforboostingthepromotionofclinicalresearchthroughsocialmedia
AT wardedward trialpromoterawebbasedtoolforboostingthepromotionofclinicalresearchthroughsocialmedia
AT wilsonmelissal trialpromoterawebbasedtoolforboostingthepromotionofclinicalresearchthroughsocialmedia
AT angyanpraveen trialpromoterawebbasedtoolforboostingthepromotionofclinicalresearchthroughsocialmedia